HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+16.45%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$157M
AUM Growth
+$157M
(+14%)
Cap. Flow
+$9.91M
Cap. Flow
% of AUM
6.33%
Top 10 Holdings %
Top 10 Hldgs %
59.23%
Holding
147
New
34
Increased
35
Reduced
16
Closed
30
Top Buys
| 1 |
IPHI
INPHI CORPORATION
IPHI
|
$3.46M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$3.43M |
| 3 |
Baidu
BIDU
|
$3.24M |
| 4 |
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
|
$2.93M |
| 5 |
DOYU
DouYu International Holdings
DOYU
|
$2.76M |
Top Sells
| 1 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
$7.15M |
| 2 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$3.49M |
| 3 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
$3.16M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$2.99M |
| 5 |
Alibaba
BABA
|
$1.05M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 27.25% |
| 3 | Financials | 7.02% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIL
26
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1M | 0.64% |
68,235
+15,894
| +30% | +$234K |
|
27
Cytokinetics
CYTK
$5.98B
| $987K | 0.63% |
+47,520
| New | +$987K |
|
28
Neurogene
NGNE
$284M
| $983K | 0.63% |
69,727
+30,493
| +78% | +$430K |
|
29
Sarepta Therapeutics
SRPT
$1.98B
| $966K | 0.62% |
+5,667
| New | +$966K |
|
30
TSMC
TSM
$1.2T
| $955K | 0.61% |
8,756
-1,244
| -12% | -$136K |
|
31
Iovance Biotherapeutics
IOVA
$800M
| $948K | 0.61% |
20,423
+3,599
| +21% | +$167K |
|
|
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $931K | 0.59% |
12,120
+4,699
| +63% | +$361K |
|
33
Amicus Therapeutics
FOLD
$2.42B
| $918K | 0.59% |
39,774
+6,881
| +21% | +$159K |
|
|
CNST
34
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $918K | 0.59% |
31,881
+12,217
| +62% | +$352K |
|
|
SWTX
35
DELISTED
SpringWorks Therapeutics
SWTX
| $900K | 0.57% |
12,412
+935
| +8% | +$67.8K |
|
36
Axsome Therapeutics
AXSM
$6.09B
| $897K | 0.57% |
11,013
+5,001
| +83% | +$407K |
|
|
CCXI
37
DELISTED
ChemoCentryx, Inc.
CCXI
| $896K | 0.57% |
14,475
+5,080
| +54% | +$314K |
|
38
Celldex Therapeutics
CLDX
$1.57B
| $873K | 0.56% |
49,855
+5,026
| +11% | +$88K |
|
|
ADAP
39
Adaptimmune Therapeutics
ADAP
$13.9M
| $859K | 0.55% |
159,351
+103,872
| +187% | +$560K |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $838K | 0.54% |
9,681
+499
| +5% | +$43.2K |
|
41
Immunovant
IMVT
$2.91B
| $827K | 0.53% |
17,905
| – | – |
|
42
argenx
ARGX
$44.2B
| $818K | 0.52% |
2,783
+725
| +35% | +$213K |
|
43
Altimmune
ALT
$325M
| $816K | 0.52% |
+72,378
| New | +$816K |
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $809K | 0.52% |
117,060
+21,085
| +22% | +$146K |
|
45
Kura Oncology
KURA
$732M
| $807K | 0.52% |
24,708
-125
| -0.5% | -$4.08K |
|
46
MacroGenics
MGNX
$121M
| $791K | 0.51% |
34,605
+16,461
| +91% | +$376K |
|
47
Ascendis Pharma
ASND
$12.1B
| $789K | 0.5% |
4,731
+1,424
| +43% | +$237K |
|
|
MRTX
48
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $783K | 0.5% |
3,563
+163
| +5% | +$35.8K |
|
49
Acadia Pharmaceuticals
ACAD
$4.34B
| $767K | 0.49% |
14,344
+1,915
| +15% | +$102K |
|
|
GBT
50
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $753K | 0.48% |
17,389
+9,840
| +130% | +$426K |
|